Kudco

Kremers Urban Pharmaceuticals, commonly known as Kudco, is a specialty generic pharmaceutical company that focuses on the development and commercialization of complex generic drug products. The company is particularly recognized for its expertise in difficult-to-manufacture oral solid dose forms, including extended-release and specialty delivery technologies. Historically based in Princeton, New Jersey, with significant manufacturing operations in Seymour, Indiana, Kremers Urban has maintained a portfolio spanning therapeutic areas such as gastroenterology, neurology, and cardiovascular health. In 2015, the company was acquired by Lannett Company for approximately $1.23 billion, integrating its high-value products like generic Nexium and Concerta into Lannett's broader offerings. Despite regulatory challenges regarding the bioequivalence rating of some products, Kudco remains a significant name in the history of the U.S. generic drug industry.